Sleep study with gamma-hydroxybutyrate in intensive care patients
Part of Brain & nervous system, Mental health clinical trials.
This study tests a drug that helps people sleep and looks at brain activity during sleep in ICU patients. It aims to see if this drug can improve sleep for patients recovering in the intensive care unit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been in the intensive care unit (ICU) for more than 48 hours.
- You can give your consent to take part.
- You do not have severe medical conditions like unstable health, severe high blood pressure, or liver problems.
- You are not taking certain medications (like barbiturates or opioids) or have conditions like sleep apnea or alcoholism.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding ketamine to standard sedation helps people wake up faster and recover better after being on a breathing machine. It may reduce confusion and improve outcomes for critically ill patients.
This study measures sleep quality in patients hospitalized in intensive care who need help breathing. Researchers will use EEG (brain wave monitoring) to see if tracking sleep helps improve patient care and outcomes.
This study tests whether personalized nighttime nursing care can improve sleep quality and health outcomes for conscious patients in the intensive care unit. Researchers believe better sleep may help patients recover faster and have better long-term health.
This study tests whether giving a medicine called dexmedetomidine (which helps people relax and sleep) as part of a sleep-promoting routine can reduce confusion and delirium in the intensive care unit (ICU). It may help you sleep better and recover more smoothly.
This study tracks how sleep in intensive care unit (ICU) patients changes over time. The goal is to better understand sleep patterns to help improve care and recovery for critically ill patients.
This trial tests a new medication, HBS-301, in people with idiopathic hypersomnia (a condition causing excessive sleepiness without clear cause). It aims to see if the drug improves wakefulness and is safe.
Hear when a new Critical Care trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.